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Reading the review article “Childhood Febrile 
Seizures: Overview and Implications” by Jones and 
Jacobsen that was recently published in International 
Journal of Medical Sciences (Int J Med Sci 2007; 4:110-114, 
http://www.medsci.org/v04p0110.htm), we noticed 
some points which we believe are worth mentioning. 
Additionally, we would like to report our own data 
from a large prospective study with a long-term follow 
up. 
The authors make a brief reference to the 
predictors of febrile seizure (FS) recurrence; however 
they do not distinguish between the first recurrence 
and further ones. In our recently published study we 
identified not only the prognostic factors for the first 
recurrence but also for further ones. Statistical analysis 
showed as significant prognostic factors for the first 
recurrence of FS: low age at onset (< 18 months), low 
duration of fever (< 12 hours), height of fever up to 
38.5oC, recurrence within the same febrile illness, 
neurological abnormalities, family history of FS and 
particularly maternal preponderance. The latter one is 
an extremely strong prognostic marker, for the first 
time mentioned in literature. Prognostic factors for the 
second or further recurrences revealed that the factors 
retaining their prognostic value were: family history of 
FS and low age at onset. The rest factors lost their 
power for the prognosis of multiple recurrences [3].  
As far as the issue of management of FS is 
concerned, intermittent rectal diazepam prophylaxis is 
found in our study to be effective and safe for the 
prevention of FS recurrence only in high-risk 
population [4]. Others have evaluated the use of oral 
diazepam prophylaxis at times of fever and 
demonstrated significant reduction in the percentage 
o f  f e b r i l e  s e i z u r e  r e c u r r e n c e  [ 5 ,  6 ]  w h o  a l s o  r e p o r t  
minor and reversible side effects. Many are concerned 
that the side effects of diazepam may delay the 
diagnosis of an underlying illness (e.g. meningitis or 
encephalitis). Infection of central nervous system must 
always be considered in case of a seizure with fever, 
especially in infants less than 18 months of age. When 
the clinician is uncertain, a lumbar puncture should be 
performed. In our opinion, parental education is 
essential and optimal management of febrile seizures 
involves preventing their recurrence only in those 
populations that are at high risk. This can be done 
most effectively with intermittent rectal diazepam 
provided that it is given at the onset of fever.  
The authors do not refer at all to the prognostic 
factors for the subsequent development of epilepsy 
after FS, which would have been a valuable additional 
parameter to be included in their review article. Major 
risk factors for the occurrence of epilepsy after FS are: 
age at onset of FS older than 3 years old, family history 
of epilepsy, complex FS and principally multiple 
episodes of FS (more than four). Rational thought is 
that since multiple febrile seizures lead to epilepsy and 
short duration seizures beget new seizures [1, 2], then 
the prevention of febrile seizures may reduce the risk 
of subsequent epilepsy. However, studies have shown 
no difference in the occurrence of epilepsy among 
children who received prophylaxis for FS and those 
without prophylaxis. It is possible that a common 
genetic predisposition is responsible for the 
development of epilepsy after FS, rather than an 
underlying lesion caused by recurrent seizures. 
However, large prospective studies are needed in 
order to verify that prevention of FS does not also 
prevent subsequent epilepsy.  
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